《市評》恆指向下 北水淨流入逾96億 阿里網易走弱
受中資科網股跌勢拖累,恆指今日(30日)向下。美國聯邦上訴法院批准特朗普政府的要求,暫停一項下級法院的裁決,暫時恢復特朗普關稅,美股道指及納指隔晚(29日)各升0.3%及0.4%,撰文之時,美國2年期債券孳息升至3.949%,美國10年期債券孳息升至4.438%,美匯指數升0.31%至99.59,道指期貨最新跌26點或0.06%,納指期貨最新跌0.2%。上證綜指全日跌15點或0.47%收3,347點,深證成指跌0.9%,滬深兩市成交額共近1.14萬億元人民幣。
港股全日反覆下跌,恆指低開233點後,中午前曾挫410點一度低見23,163點,全日收報23,289點,跌283點或1.2%;國指跌127點或1.49%,收報8,432點;恆生科技指數跌131點或2.48%,收報5,170點。大市全日成交總額按日升近20%至2,715.63億元。MSCI指數季檢於今日收市後生效。而南向資金今日淨買入96.47億元(上日淨買入43.82億元)。蘋果概念股捱沽,比亞迪電子(00285.HK)全日跌6%,舜宇(02382.HK)及瑞聲(02018.HK)各跌4.7%與4.3%。比亞迪(01211.HK)走低近3.3%。
恆指本周累跌311點或1.3%、國指本周累跌151點或1.8%、本周累跌76點或1.5%。而恆指5月累升1,170點或5.3%、國指5月累升355點或4.4%、恆生科指5月累升83點或1.6%。市場關注美國總統特朗普的「對等關稅」發展及美國與中國、其他國家貿易談判的進展等。
【科技股向下 阿里網易弱】
科技股向下,阿里(09988.HK)全日股價下滑3.6%收113.9元,騰訊(00700.HK)股價跌2.4%。網易(09999.HK)跌4.7%,MSCI中國指數收市後調整生效,中金指網易於指數權重將下滑0.175%,料被動資金流出較多,另預期百度(09888.HK)於指數權重將下降0.03%,百度全日股價跌3.7%。
高盛發表中資互聯網行業報告表示,近期投資者主要聚焦外賣競爭與電商的再投資及AI應用受益者。就內地外賣行業競爭,未來的發展路徑及最終格局是甚麼?該行估計,京東-SW(09618.HK)、美團-W(03690.HK)和阿里旗下餓了麼的增量補貼已將外賣行業的訂單量增長從中單位數推高至30%以上按年增長,提升了服務消費(加上政府「以舊換新」計劃推動了商品消費),並創造了數以十萬計新的每日騎手就業機會。該行估計京東今年第二季度新業務EBIT虧損為100億元人民幣(原先預測為70億人民幣),並料美團旗下外賣業務利潤按年下降50億至60億元人民幣(意味按年跌約53%)。
該行認為,市場可能低估了京東將外賣作為新流量獲取來源的決心(相對於其每年500億元人民幣的營銷預算,其中大部分用於客戶獲取,因京東應用的日活躍用戶規模和頻次相對同行處於劣勢),以及阿里在該業務上的投資規模,因此低估了內地外賣競爭的潛在持續時間。
【跌股千二隻 石藥受追捧】
港股今日市寬轉弱,主板股票的升跌比率為17比29(上日為32比15),下跌股份1,209隻(跌幅2.5%),恆指成份股今日21隻股份上升,下跌股60隻,升跌比率為25比72(上日78比18)。大市今日錄沽空375.53億元,佔可沽空股份成交額2,523.21億元的14.883%(上日為16.909%)。
石藥(01093.HK)正就三項潛在交易進行磋商,潛在首付款等合計約50億美元,股價全日彈高6.3%,為表現最佳藍籌股。
花旗發表報告指,石藥首季表現疲弱,收入按年下跌21.9%,盈利亦下跌8.4%,管理層預期今年其餘季度都將實現按季增長,集團公布正與獨立第三方就三項潛在交易進行磋商,涉及旗下產品的開發、生產及商業化授權及合作。基於其合理估值及優質創新藥管線的持續重估潛力,花旗相信該等交易可能成為石藥的重要催化劑,預期未來將有更多產品授權合作,將2026及2027年收入預測上調3%及2%,由於銷售費用預期下降,將2025至2027年每股盈利預測上調4%、5%及5%,目標價從9元上調至9.2元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.